Primary Prevention: Focus on preventing disease occurrence.
Examples: Immunizations, tobacco control programs.
Secondary Prevention: Early detection in clinical settings or through screening programs.
Tertiary Prevention: Improve treatment, minimize morbidity, and prevent new sequelae.
Example: Development of novel therapies.
Validity: Measures whether the test accurately indicates disease presence or absence.
Reliability: Assesses if test results are consistent upon repeated measures.
Intra-subject variability: Fluctuation in a variable over time.
Intra-observer variability: A single observer gets different results over time.
Inter-observer variability: Different observers obtain varying results on the same individual.
2 x 2 Table for Evaluating Screening:
Must know true disease state based on a gold standard.
Test results compared to findings from new tests.
Sensitivity: % of people with disease who test positive.
Formula:
Sensitivity = [True Positives / (True Positives + False Negatives)] x 100
Specificity: % of people without disease who test negative.
Formula:
Specificity = [True Negatives / (False Positives + True Negatives)] x 100
Positive Predictive Value (PPV): Likelihood that a positive test accurately indicates disease.
Formula:
PPV = [True Positives / (True Positives + False Positives)] x 100
Negative Predictive Value (NPV): Likelihood that a negative test indicates disease absence.
Formula:
NPV = [True Negatives / (True Negatives + False Negatives)] x 100
50,000 study subjects with a 0.5% prevalence of colorectal cancer.
1,800 subjects tested positive using a new molecular screening test; 200 confirmed via gold standard.
Sensitivity:
(200 disease positives / 250 total disease state) x 100 = 80%
Specificity:
(48150 true negatives / 49750 total no disease) x 100 = 96.78%
Positive Predictive Value:
(200 true positives / 1800 total positives) x 100 = 11.11%
PPV influenced mainly by specificity and disease prevalence.
Null Hypothesis (H0): Assumes no association between exposure and disease.
Relative Risk or Odds Ratio = 1.0.
Alternative Hypothesis (Ha): Suggests there is an association.
P-value indicates the probability of observing a test statistic as extreme as the one calculated under the null hypothesis.
**Type I Error (α)**: Incorrectly rejecting H0 when it's true. Commonly set at α = 0.05.
Type II Error (β): Failing to reject H0 when it's false.
Power = 1 - β: Probability of detecting an effect if one exists.
A range indicating where the true population parameter lies.
Example: For RR = 1.5, CI = 1.2 - 1.8 indicates plausible values.
As sample size increases, confidence interval width decreases, enhancing precision.
Random Error: Chance-related errors in measurements.
Systematic Error: Errors arising from identifiable biases or confounding effects.
Internal Validity: Reflects the accuracy in determining cause-effect relationships.
External Validity (Generalizability): Ability to apply findings to broader populations.
Increase sample size to reduce random error.
Conduct repeated measures to improve reliability.
Illustrative examples in teaching public health concepts, including references to Type I errors and hypothesis rejection.